These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1159 related items for PubMed ID: 19931732

  • 1. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.
    van den Belt-Dusebout AW, Aleman BM, Besseling G, de Bruin ML, Hauptmann M, van 't Veer MB, de Wit R, Ribot JG, Noordijk EM, Kerst JM, Gietema JA, van Leeuwen FE.
    Int J Radiat Oncol Biol Phys; 2009 Dec 01; 75(5):1420-9. PubMed ID: 19931732
    [Abstract] [Full Text] [Related]

  • 2. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C.
    Haematologica; 1998 Sep 01; 83(9):812-23. PubMed ID: 9825578
    [Abstract] [Full Text] [Related]

  • 3. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW, de Wit R, Gietema JA, Horenblas S, Louwman MW, Ribot JG, Hoekstra HJ, Ouwens GM, Aleman BM, van Leeuwen FE.
    J Clin Oncol; 2007 Oct 01; 25(28):4370-8. PubMed ID: 17906202
    [Abstract] [Full Text] [Related]

  • 4. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
    De Bruin ML, Sparidans J, van't Veer MB, Noordijk EM, Louwman MW, Zijlstra JM, van den Berg H, Russell NS, Broeks A, Baaijens MH, Aleman BM, van Leeuwen FE.
    J Clin Oncol; 2009 Sep 10; 27(26):4239-46. PubMed ID: 19667275
    [Abstract] [Full Text] [Related]

  • 5. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW, Nuver J, de Wit R, Gietema JA, ten Bokkel Huinink WW, Rodrigus PT, Schimmel EC, Aleman BM, van Leeuwen FE.
    J Clin Oncol; 2006 Jan 20; 24(3):467-75. PubMed ID: 16421423
    [Abstract] [Full Text] [Related]

  • 6. Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment.
    Rubino C, Shamsaldin A, Lê MG, Labbé M, Guinebretière JM, Chavaudra J, de Vathaire F.
    Breast Cancer Res Treat; 2005 Feb 20; 89(3):277-88. PubMed ID: 15754127
    [Abstract] [Full Text] [Related]

  • 7. Second primary cancers in patients with stage III non-small cell lung cancer successfully treated with chemo-radiotherapy.
    Kawaguchi T, Matsumura A, Iuchi K, Ishikawa S, Maeda H, Fukai S, Komatsu H, Kawahara M.
    Jpn J Clin Oncol; 2006 Jan 20; 36(1):7-11. PubMed ID: 16368713
    [Abstract] [Full Text] [Related]

  • 8. [Long-term complications following treatment of testicular cancer and Hodgkin lymphoma].
    van den Belt-Dusebout AW, Aleman BM, Gietema JA, de Wit R, van 't Veer MB, Lugtenburg PJ, Krol AD, van Leeuwen FE.
    Ned Tijdschr Geneeskd; 2010 Jan 20; 154(45):A2229. PubMed ID: 21118593
    [Abstract] [Full Text] [Related]

  • 9. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG, Broglia C, Levis A, La Sala A, Valentino F, Chisesi T, Sacchi S, Corbella F, Cavanna L, Iannitto E, Pavone V, Molica S, Corazza GR, Federico M.
    Clin Cancer Res; 2006 Jan 15; 12(2):529-35. PubMed ID: 16428496
    [Abstract] [Full Text] [Related]

  • 10. Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma.
    Hodgson DC, Koh ES, Tran TH, Heydarian M, Tsang R, Pintilie M, Xu T, Huang L, Sachs RK, Brenner DJ.
    Cancer; 2007 Dec 01; 110(11):2576-86. PubMed ID: 17941006
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.
    van Eggermond AM, Schaapveld M, Janus CP, de Boer JP, Krol AD, Zijlstra JM, van der Maazen RW, Kremer LC, van Leerdam ME, Louwman MW, Visser O, De Bruin ML, Aleman BM, van Leeuwen FE.
    Br J Cancer; 2017 Jul 25; 117(3):306-314. PubMed ID: 28632726
    [Abstract] [Full Text] [Related]

  • 13. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.
    van Leeuwen FE, Klokman WJ, Stovall M, Hagenbeek A, van den Belt-Dusebout AW, Noyon R, Boice JD, Burgers JM, Somers R.
    J Natl Cancer Inst; 1995 Oct 18; 87(20):1530-7. PubMed ID: 7563187
    [Abstract] [Full Text] [Related]

  • 14. Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields.
    Nguyen F, Rubino C, Guerin S, Diallo I, Samand A, Hawkins M, Oberlin O, Lefkopoulos D, De Vathaire F.
    Int J Radiat Oncol Biol Phys; 2008 Mar 01; 70(3):908-15. PubMed ID: 18262102
    [Abstract] [Full Text] [Related]

  • 15. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
    Aleman BM, Raemaekers JM, Tomiŝiĉ R, Baaijens MH, Bortolus R, Lybeert ML, van der Maazen RW, Girinsky T, Demeestere G, Lugtenburg P, Lievens Y, de Jong D, Pinna A, Henry-Amar M, European Organization for Research and Treatment of Cancer (EORTC) Lymphoma Group.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):19-30. PubMed ID: 17097834
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group.
    Tucker MA, Jones PH, Boice JD, Robison LL, Stone BJ, Stovall M, Jenkin RD, Lubin JH, Baum ES, Siegel SE.
    Cancer Res; 1991 Jun 01; 51(11):2885-8. PubMed ID: 1851664
    [Abstract] [Full Text] [Related]

  • 17. Malignant breast tumors after radiotherapy for a first cancer during childhood.
    Guibout C, Adjadj E, Rubino C, Shamsaldin A, Grimaud E, Hawkins M, Mathieu MC, Oberlin O, Zucker JM, Panis X, Lagrange JL, Daly-Schveitzer N, Chavaudra J, de Vathaire F.
    J Clin Oncol; 2005 Jan 01; 23(1):197-204. PubMed ID: 15625374
    [Abstract] [Full Text] [Related]

  • 18. Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma.
    Koh ES, Sun A, Tran TH, Tsang R, Pintilie M, Hodgson DC, Wells W, Heaton R, Gospodarowicz MK.
    Int J Radiat Oncol Biol Phys; 2006 Sep 01; 66(1):223-8. PubMed ID: 16904523
    [Abstract] [Full Text] [Related]

  • 19. Accounting for smoking in the radon-related lung cancer risk among German uranium miners: results of a nested case-control study.
    Schnelzer M, Hammer GP, Kreuzer M, Tschense A, Grosche B.
    Health Phys; 2010 Jan 01; 98(1):20-8. PubMed ID: 19959947
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study.
    Haugnes HS, Wethal T, Aass N, Dahl O, Klepp O, Langberg CW, Wilsgaard T, Bremnes RM, Fosså SD.
    J Clin Oncol; 2010 Oct 20; 28(30):4649-57. PubMed ID: 20855830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.